AcryMed Tissue Repair and Wound Healing Technologies


AcryMed has developed and patented a broad range of core platform technologies, many of which have resulted in well-recognized commercial products in the advanced wound healing and tissue repair markets. The company’s focused research efforts have produced technologies with unique properties and potentially vast market applicability, specifically in the area of wound moisture management, therapeutic agent delivery, topical oxygen to enhance tissue healing response and methods for controlled release of antimicrobial agents to fight infections.

In the area of controlled release technology, AcryMed’s research efforts have yielded a wide array of applications, which include thin films, foams, topicals and hydrogels. The company’s SilvaSorb® technology provides for controlled-release silver antimicrobial and is extremely effective in killing a broad-spectrum of infection-causing bacteria, including MRSA and other antibiotic resistant strains.

AcryMed will continue to focus on leading-edge innovations to address un-met clinical needs, while seeking additional business opportunities through license agreements of its patented technologies in the wound care and infection control markets.




Controlled Release Antimicrobial

Dissolved Oxygen

Nail Fungus Treatment

MicroLattice® Matrix